There are 302 resources available
Q&A and discussion
Session: International IO trial activity by not-for-profit cooperative groups
Resources:
Webcast
Q&A and discussion
Session: Secondary IO refractory cancers
Resources:
Webcast
Q&A and discussion
Session: Future directions for radio-immuno-oncology
Resources:
Webcast
Expectations for the design of IO trials
Presenter: Francesco Pignatti
Session: Criteria and methodologies of evaluation for novel IO
Resources:
Slides
Webcast
Project Optimus: Drug dose finding in immuno-oncology
Presenter: Stephane Champiat
Session: Criteria and methodologies of evaluation for novel IO
Resources:
Slides
Webcast
Anti-CD73 immunotherapy: From bench to bedside
Presenter: Laurence Buisseret
Session: Investigator initiated trials: Driven by immunology
Resources:
Slides
Webcast
New organisation of HTA at the European levels
Presenter: Pierre Cochat
Session: Criteria and methodologies of evaluation for novel IO
Resources:
Slides
Webcast
Simpler and more relevant trials
Presenter: Teresa Amaral
Session: Criteria and methodologies of evaluation for novel IO
Resources:
Slides
Webcast
Intratumoural TLR9 agonists in melanoma
Presenter: Tanja de Gruijl
Session: Investigator initiated trials: Driven by immunology
Resources:
Slides
Webcast
Q&A and discussion
Session: Criteria and methodologies of evaluation for novel IO
Resources:
Webcast